Literature DB >> 18280846

Circumcision and risk of sexually transmitted infections in a birth cohort.

Nigel P Dickson1, Thea van Roode, Peter Herbison, Charlotte Paul.   

Abstract

OBJECTIVE: To determine the impact of early childhood circumcision on sexually transmitted infection (STI) acquisition to age 32 years. STUDY
DESIGN: The circumcision status of a cohort of children born in 1972 and 1973 in Dunedin, New Zealand was sought at age 3 years. Information about STIs was obtained at ages 21, 26, and 32 years. The incidence rates of STI acquisition were calculated, taking into account timing of first sex, and comparisons were made between the circumcised men and uncircumcised men. Adjustments were made for potential socioeconomic and sexual behavior confounding factors where appropriate.
RESULTS: Of the 499 men studied, 201 (40.3%) had been circumcised by age 3 years. The circumcised and uncircumcised groups differed little in socioeconomic characteristics and sexual behavior. Overall, up to age 32 years, the incidence rates for all STIs were not statistically significantly different-23.4 and 24.4 per 1000 person-years for the uncircumcised and circumcised men, respectively. This was not affected by adjusting for any of the socioeconomic or sexual behavior characteristics.
CONCLUSIONS: These findings are consistent with recent population-based cross-sectional studies in developed countries, which found that early childhood circumcision does not markedly reduce the risk of the common STIs in the general population in such countries.

Entities:  

Mesh:

Year:  2007        PMID: 18280846     DOI: 10.1016/j.jpeds.2007.07.044

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  11 in total

1.  Canadian Urological Association guideline on the care of the normal foreskin and neonatal circumcision in Canadian infants (full version).

Authors:  Sumit Dave; Kourosh Afshar; Luis H Braga; Peter Anderson
Journal:  Can Urol Assoc J       Date:  2017-12-01       Impact factor: 1.862

Review 2.  What is the medical evidence on non-therapeutic child circumcision?

Authors:  Matthew Deacon; Gordon Muir
Journal:  Int J Impot Res       Date:  2022-01-08       Impact factor: 2.896

3.  The Authors' Reply.

Authors:  Morten Frisch; Jacob Simonsen
Journal:  Eur J Epidemiol       Date:  2022-06-20       Impact factor: 12.434

4.  Sexually transmitted infections and male circumcision: a systematic review and meta-analysis.

Authors:  Robert S Van Howe
Journal:  ISRN Urol       Date:  2013-04-16

5.  Is Sex Like Driving? HIV Prevention and Risk Compensation.

Authors:  Nicholas L Wilson; Wentao Xiong; Christine L Mattson
Journal:  J Dev Econ       Date:  2013-09-09

Review 6.  Behavioral aspects of male circumcision for the prevention of HIV infection.

Authors:  Lisa Eaton; Seth C Kalichman
Journal:  Curr HIV/AIDS Rep       Date:  2009-11       Impact factor: 5.071

Review 7.  The past, present, and future of HIV prevention: integrating behavioral, biomedical, and structural intervention strategies for the next generation of HIV prevention.

Authors:  Mary Jane Rotheram-Borus; Dallas Swendeman; Gary Chovnick
Journal:  Annu Rev Clin Psychol       Date:  2009       Impact factor: 18.561

8.  Adult male circumcision does not reduce the risk of incident Neisseria gonorrhoeae, Chlamydia trachomatis, or Trichomonas vaginalis infection: results from a randomized, controlled trial in Kenya.

Authors:  Supriya D Mehta; Stephen Moses; Kawango Agot; Corette Parker; Jeckoniah O Ndinya-Achola; Ian Maclean; Robert C Bailey
Journal:  J Infect Dis       Date:  2009-08-01       Impact factor: 5.226

Review 9.  Does Male Circumcision Protect against Sexually Transmitted Infections? Arguments and Meta-Analyses to the Contrary Fail to Withstand Scrutiny.

Authors:  Brian J Morris; Catherine A Hankins; Aaron A R Tobian; John N Krieger; Jeffrey D Klausner
Journal:  ISRN Urol       Date:  2014-05-13

10.  Male circumcision and Neisseria gonorrhoeae, Chlamydia trachomatis and Trichomonas vaginalis: observations after a randomised controlled trial for HIV prevention.

Authors:  J Sobngwi-Tambekou; D Taljaard; M Nieuwoudt; P Lissouba; A Puren; B Auvert
Journal:  Sex Transm Infect       Date:  2008-12-15       Impact factor: 3.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.